COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,390 Articles (22,816 medRxiv, 8,574 bioRxiv)

Most recent first Previous |  Page 2102: Articles 21011-21020  | Next

Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago
Qiang, M., Ma, P., Li, Y., Liu, H., Harding, A., Min, C., Liu, L., Yuan, M., Ji, Q., Tao, P., Shi, X., Li, Z., Wang, F., Zhang, Y., Wu, N. C., Lee, C.-C. D., Zhu, X., Gilbert-Jaramillo, J., Saxena, A., Huang, X., Wang, H., James, W., Dwek, R. A., Wilson, I. A., Yang, G., Lerner, R. A.
10.1101/2020.11.06.370676 — Posted: 2020-11-06 Discussion: Offsite
Differing impacts of global and regional responses on SARS-CoV-2 transmission cluster dynamics
Rife Magalis, B., Ramirez-Mata, A., Zhukova, A., Mavian, C., Marini, S., Lemoine, F., Prosperi, M., Gascuel, O., Salemi, M.
10.1101/2020.11.06.370999 — Posted: 2020-11-06
Genomic and phenotypic analysis of COVID-19-associated pulmonary aspergillosis isolates of Aspergillus fumigatus
Steenwyk, J. L., Mead, M. E., Castro, P. A., Valero, C., Damasio, A., Santos, R. A. C., LaBella, A. L., Li, Y., Knowles, S. L., Raja, H. A., Oberlies, N. H., Zhou, X., Cornely, O. A., Fuchs, F., Koehler, P., Goldman, G., Rokas, A.
10.1101/2020.11.06.371971 — Posted: 2020-11-06
Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
Sherina, N., Piralla, A., Du, L., Wan, H., Kumagai-Braesh, M., Andrell, J., Braesch-Andersen, S., Cassaniti, I., Percivalle, E., Sarasini, A., Bergami, F., Di Martino, R., Colaneri, M., Vecchia, M., Sambo, M., Zuccaro, V., Bruno, R., Oggionni, T., Meloni, F., Abolhassani, H., Bertoglio, F., Schubert, M., Byrne-Steele, M., Han, J., Hust, M., Xue, Y., Hammarstrom, L., Baldanti, F., Marcotte, H., Pan-Hammarstrom, Q.
10.1101/2020.11.06.371617 — Posted: 2020-11-06
Nodosome inhibition as a novel broad-spectrum antiviral strategy against arboviruses and SARS-CoV-2
Limonta, D., Dyna-Dagman, L., Branton, W., Makio, T., Wozniak, R. W., Power, C., Hobman, T. C.
10.1101/2020.11.05.370767 — Posted: 2020-11-06
Exosome-Mediated mRNA Delivery For SARS-CoV-2 Vaccination
Tsai, S.-J., Guo, C., Atai, N. A., Gould, S. J.
10.1101/2020.11.06.371419 — Posted: 2020-11-06 Discussion: Onsite | Offsite
Allosteric hotspots in the main protease of SARS-CoV-2
Strömich, L., Wu, N., Barahona, M., Yaliraki, S. N.
10.1101/2020.11.06.369439 — Posted: 2020-11-06
Acrylamide Fragment Inhibitors that Induce Unprecedented Conformational Distortions in Enterovirus 71 3C and SARS-CoV-2 Main Protease
Qin, B., Craven, G. B., Hou, P., Lu, X., Child, E. S., Morgan, R. M. L., Armstrong, A., Mann, D. J., Cui, S.
10.1101/2020.11.06.370916 — Posted: 2020-11-06
Spatial Profiling of Lung SARS-CoV-2 and Influenza Virus Infection Dissects Virus-Specific Host Responses and Gene Signatures
Kulasinghe, A., Tan, C. W., Miggiolaro, A. F. R. d. S., Monkman, J., Bhuva, D., Junior, J. d. S. M., de Paula, C. B. V., Nagashima, S., Baena, C. P., Guimaraes, P. S.-F., Noronha, L., McCulloch, T., Rossi, G. R., Cooper, C., Tang, B., Short, K., Davis, M. J., Guimaraes, F. S.-F., Belz, G. T., O'Byrne, K.
10.1101/2020.11.04.20225557 — Posted: 2020-11-06
Community health worker knowledge, attitudes and practices towards COVID-19: learnings from an online cross-sectional survey using a digital health platform, UpSCALE, in Mozambique
Feldman, M., Lacey Krylova, V., Farrow, P., Donovan, L., Zandamela, E., Rebelo, J., Rodrigues, M., Bulo, A., Ferraz, C., Romero Gonzalez, J., Rodrigues, H., Roca-Feltrer, A., Baker, K.
10.1101/2020.11.05.20216606 — Posted: 2020-11-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).